Keywords
Highlighted Topics
Most Viewed Questions And Answers
-
Does all research go through the same review process?
No. There are three types of research, each of which receives a different level of review.
- Exempt Research
The University of Washington applies the federal regulations and guidance about exemption to all UW human subjects research, regardless of funding or funding source. The staff of the Human Subjects Division (HSD) are the only individuals authorized to determine that research activity is exempt from federal regulations. In addition to the federal criteria, HSD requires that exempt research involve no more than minimal risk and that interactions with subjects must include some type of consent process that provides the subjects with basic information about the research.
Researchers do not have the authority to determine that their own research qualifies for exempt status. The research may not begin until the researcher has received notification from HSD that the research qualifies for exemption. Exempt status is granted for a five-year period.
- Minimal Risk Research
Research falling into minimal risk categories is reviewed by a subcommittee of the IRB (use form UW 13-11). You may also hear the term "expedited review" used in conjunction with the review of minimal risk research; describing the ability of the research to be reviewed by a subcommittee - not that the review process is necessarily faster.
- More than Minimal Risk Research
Research falling into categories considered to be of more than minimal risk requires review by the full Committee (use form UW 13-11).
- Exempt Research
-
How long does the IRB review process take?
Multiple factors affect the time required for IRB review. They include:
- type of application
- level of review (e.g., exempt, minimal risk, full committee)
- complexity of the study
- involvement of other compliance offices or institutions
- quality and completeness of the application when first submitted
We encourage researchers to plan for sufficient time for review based on the research and their particular situation. Here are some general recommendations based on HSD's current workload:
- Allocate adequate preparation time before submission, in most cases a minimum of two weeks to one month.
- For full IRB review, plan for at least 12 to 16 weeks for the review and approval process.
- For Minimal Risk review, plan for at least 6 to 8 weeks.
- For Exempt review, plan for at least 2 to 3 weeks.
-
What is needed to request a "Waiver of HIPAA Authorization?"
The UW IRB Committees use specific criteria in reviewing requests for a waiver of HIPAA authorization for research. In completing the Human Subjects Review Application (UW 13-11), researchers should explain how:
- The use or disclosure of protected health information involves no more than minimal risk to the privacy, safety, and welfare of the individual;
- The research could not practicably be conducted without the waiver or alteration;
- The research could not practicably be conducted without access to the protected health information;
- There is an adequate plan to protect the identifiers from improper use or disclosure;
- There is an adequate plan to destroy the identifiers at the earliest opportunity consistent with conduct of the research, unless there is a health or research justification for retaining the identifiers or such retention is otherwise required by law; and
- There are adequate written assurances that the protected health information will not be re-used or disclosed to a third party except as required by law, for authorized oversight of the research, or as permitted by an authorization signed by the research subject
In requesting this waiver, researchers should also provide the following information:
- Detailed information about the types of protected health information that will be used, including how it will be used, who will have access to it, and when it will be destroyed;
- What risks are posed by the use of the data, and how they have been minimized
- The justification for access to the data and why they are necessary to conduct the research.
-
What is research?
"Research" means a systematic investigation designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute "research" for the purposes of the regulations that guide and govern how research is conducted in the United States, whether or not they are supported or funded under a program which is considered research for other purposes. For example, some "demonstration" and "service" programs may include research activities. It may be important to understand the following about research:
- It is basically a study that is done to answer a question.
- Scientists do research because they don't know for sure what works best or to better understand why or how things happen.
- Some other words that describe research are clinical trial, protocol, survey, or experiment.
- Research is not the same as treatment.
-
What should my consent form contain?
Guidance is available regarding consent, including sample forms, on the Consent, Assent and Waivers topic page.
- Everything
- Documents
- Keywords
- 0-9 |
- A |
- B |
- C |
- D |
- E |
- F |
- G |
- H |
- I |
- J |
- K |
- L |
- M |
- N |
- O |
- P |
- Q |
- R |
- S |
- T |
- U |
- V |
- W |
- X |
- Y |
- Z
A
- About HSD
- About the IRB
- Adverse Events and Unanticipated Problems
- Air Force
- alteration
- annual review
- Apply for Review
- Approaching and Recruiting Prospective Subjects
- Approaching and Recruiting Prospective Subjects - Advertisements
- Approaching and Recruiting Prospective Subjects - Intermediaries
- Approaching and Recruiting Prospective Subjects - Pre-Screening Records
- Approaching and Recruiting Prospective Subjects - Screening
- Approaching and Recruiting Prospective Subjects - Telephone
- Approaching and Recruiting Prospective Subjects - Web-Based
- approval
- Approval in Principle
- Army
- assurance information
B
C
- Cancer Consortium IRB at the Fred Hutchinson Cancer Research Center
- Case Reports
- CC-IRB
- Certificates of Confidentiality
- change
- Check Status
- Check the IRB meeting schedule
- classified
- clinical research
- Clinical Trials
- ClinicalTrials.gov
- Closing a Study and IRB Application
- co-investigators
- cognitive impairment
- committee meetings
- communications
- Compensation for IRB Members
- Compensation of Subjects
- conclude
- Conditional Approval
- Conduct of Research and Reporting
- confidential
- confidential data
- confidentiality agreement
- Consent, Assent and Waivers
- contingent
- Continuing Review
- Contract and Consent Form Comparison
- Cooperative Agreement: Cancer Research and Biostatistics (CRAB)
- Cooperative Agreement: Fred Hutchinson Cancer Research Center (FHCRC)
- Cooperative Agreement: Group Health Cooperative (GHC)
- Cooperative Agreement: Seattle Children's
- Cooperative Agreement: Swedish Medical Center
- Cooperative Agreement: Virginia Mason Medical Center / Benaroya Research Institute (VMMC/BRI)
- Cooperative Agreement: Washington State Institutional Review Board (WSIRB)
- Cooperative Agreements
D
- Data Safety and Monitoring
- data security
- data sets
- dataset
- De-Identified Information
- Deception
- Definition of Research
- Delayed Onset Human Research (DOHR)
- Department of Defense (DoD) Research
- Department Review and Approval
- dependent on
- DoD
- DoD regulations
- Does Your Research Involve Human Subjects
- DORA
- DSMP
E
- end
- Ending the Study
- Engagement
- enroll
- entire IRB
- ethics committee
- Exempt Status Request and Determination
- exemption
- expire
F
- federal certificate
- Federal Regulations
- Federalwide Assurance (FWA)
- fetus
- Food and Drug Administration (FDA) Research
- Full IRB Review
G
- genetics
- Genetics Research
- Genetics Research - 13 Questions
- Genome-Wide Association Studies, Database of Genotypes and Phenotypes
- Get Started
- government requirements
- greater than minimal risk review
- GWAS dbGaP Studies
H
- Health Insurance Portability and Accountability Act
- HIPAA and Research
- HSD metrics
- HSD New Staff Training
- human DNA
- Human Research Subjects
- human subjects research committee
I
- identifiable research data
- identification
- identifiers
- identify
- Individuals Incapable of Consenting
- industry-sponsored research
- infraction
- institutional protection
- Institutional Review Board
- interagency agreement
- internet research
- Internet-Based Research
- Investigational Devices
- investigator
- IRB
- IRB Committees
- IRB Member Conflict of Interest
- IRB process
- IRB Registration (Assurance) Numbers
- IRB Review and Determinations/Actions
- IRB Review Types
- Is the UW the Right IRB for Review
- Is Your Project Considered Research
J
K
L
M
- Marines
- measure
- medical
- Medical Records Review
- metric
- Minimal Risk (Expedited) Review
- Modification - Changing Your Research
- Modify or Renew an Application
N
- native
- Native American
- Navy
- neonate
- NIH issued certificate
- non-human subject
- noncompliance
- nonobservance
- not employed by the University of Washington
- Not Human Subjects Research
- not subject to further review
O
P
- partial
- payment
- permission
- personal
- personal identification
- PHI
- pregnant
- principal investigator
- prisoner
- Protected and Vulnerable Populations
- protected health information
- Public Data Sets
- public information
R
- Radiation Safety
- recruitment
- reimburse
- renewal
- Report a problem with my research / study
- Report Problems (Compliance)
- Repositories
- research candidates
- research data
- Research Non-Compliance and the IRB
- Research Participant
- Researcher Conflict of Interest
- Researcher Preparation
- Researcher Responsibilities
- restricted
- reward
S
- sample
- sanction
- Seattle Cancer Care Alliance
- sign up
- social networking
- status report
- stop
- Students
- subject confidentiality
- subject data
- subject payment
- Subject Privacy, Confidentiality and Identifiable Data
- subject safety
T
- taste and food quality evaluation
- The Discussion Board
- timeline
- tissue samples
- Training Requirements
- Training Requirements - Department of Defense (DoD) Requirements
- turn-around
U
- unexpected
- unforeseen
- unidentified
- Use of Identifiable Specimens/Data
- UW IRB Review of Clinical Trials

| 